Science 37 Introduces Native Support for Apple and Android
Science 37 has created a patient experience while introducing native support for iOS and Android operating systems. With this development, patients can not only participate from the comfort of their own home, but they can also do it with the familiarity of their own smartphones.
Using their own devices (BYOD), patients can learn more about a study, provide consent, schedule and participate in study visits, complete assessments, and communicate directly with the Science 37 study team and investigators, all through a single platform.
The intuitive, cloud-based platform also integrates workflow and processes for physician investigators, mobile nurses, and coordinators across the entire trial life cycle. Combining these advantages with native support for iOS and Android further enhances the company’s ability to deploy its services globally.
Chris Ceppi, chief product officer of Science 37 says, “The fully integrated mobile capabilities we’re introducing enable a patient experience that sets a new standard for clinical studies.”
In addition to the platform, Science 37 has also conducted more fully decentralized, interventional clinical trials-all the way from protocol design to database lock. Coupled with its telemedicine and home health network, Science 37 enables coverage around the world.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
